Skip to main content
. Author manuscript; available in PMC: 2014 Jul 16.
Published in final edited form as: Ann Surg Oncol. 2012 May;19(5):1386–1393. doi: 10.1245/s10434-012-2241-6

FIG. 1.

FIG. 1

a Kaplan–Meier overall survival curve for all patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (n = 282). Median survival was 6.72 years (95% CI, 4.17 years, not reached); 3- and 5- year overall survival probability was 67.4 and 52.7%, respectively. b Kaplan–Meier curve for time to progression for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (n = 214). Median time to progression was 1.79 years (95% CI, 1.56–2.48); 3- and 5- year overall survival probability was 45.1 and 32.1% respectively